PCG Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

PCG Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$291K	Hold	4,800	–	–	0.23%	69
2025 Q4	$264K	Sell	4,800 -225	-4%	-$10.8K	0.21%	69
2025 Q3	$227K	Sell	5,025 -125	-2%	-$5.84K	0.18%	74
2025 Q2	$238K	Hold	5,150	–	–	0.2%	71
2025 Q1	$314K	Sell	5,150 -100	-2%	-$5.83K	0.29%	59
2024 Q4	$297K	Buy	+5,250	New	+$293K	0.26%	65

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCG Asset Management's BMY Position: Q1 2026 in Review

PCG Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 4,800 shares worth $291K. The position accounts for 0.23% of the portfolio, ranked #69.

PCG Asset Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $314K in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

PCG Asset Management held 4,800 shares of Bristol-Myers Squibb worth $291K as of Q1 2026.
PCG Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.23% of PCG Asset Management's portfolio in Q1 2026, its #69 holding.
PCG Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
PCG Asset Management's Bristol-Myers Squibb position peaked at $314K in Q1 2025.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on PCG Asset Management's 13F filing for Q1 2026, filed 12 May 2026.